Latest Blood Stories

A new study from the University of Cincinnati (UC) College of Medicine has found that, when delivered via ultrasound, the natural enzyme plasmin is more effective at dissolving stroke-causing clots than the standard of care, recombinant tissue plasminogen activator (rt-PA). The novel delivery method involved trapping plasmin into bubble-like liposomes, delivering them to the clot intravenously and bursting it via ultrasound. That method is necessary, says UC associate professor of...

Company Generated Record First Quarter Cash From Operations of $128,970 LAS VEGAS, May 15, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended March 31, 2013. First Quarter 2013 Highlights From Continuing Operations Recurring revenues increased approximately 7% for the three months ended March 31, 2013 to $740,124. Cash provided by operations totaled...

Company Offers Chance to Win Free Cord Blood Banking NEW YORK, May 13, 2013 /PRNewswire/ -- Americord Registry is pleased to announce that it is attending the New York Baby Show at Pier 92 in New York City May 18(th) and 19(th). The event will feature leading companies in the baby industry that will be showcasing the newest and most exciting products for expecting mothers and newborn babies. The event is an opportunity to engage representatives from companies to get the most...

Research adds to the growing body of evidence of neutrophils' role in dangerous blood clots BOSTON, May 6, 2013 /PRNewswire-USNewswire/ -- It takes more than platelets, thrombin and fibrin to build a deep vein thrombosis (DVT). Increasingly, researchers are recognizing that neutrophils--cells better known for their role in immune defense--play an active role in DVT formation by releasing platelet-catching nets made of chromatin, a tightly-wound mix of DNA and associated proteins....

German study in Psychosomatic Medicine has surprising findings on hypertension in adolescents Teenagers with high blood pressure appear to have better psychological adjustment and enjoy higher quality of life than those with normal blood pressure, suggests a study in the May issue of Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer...

New Device Surmounts Shortcomings of Existing Fingertip Sensors GLASTONBURY, Conn., May 2, 2013 /PRNewswire/ -- Assurance Biosense, a subsidiary of Xhale, Inc., today announced that it will unveil its next-generation Assurance® Alar Sensor at the International Anesthesia Research Society (IARS) meeting in San Diego May 4-7, 2013. The IARS meeting is attended by more than 1,000 of the world's leading anesthesia educators and investigators and focuses on the latest advances in...

BRAINTREE, Mass., May 1, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) today announced that it has completed its previously announced acquisition of the assets of Hemerus Medical, LLC ("Hemerus"), a Minnesota-based company that develops innovative technologies for the collection of whole blood and for the processing and storage of blood components. (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) Haemonetics recently learned that the U.S. FDA approved...

The Supermodel Joins Katharina Harf of Delete Blood Cancer and Founding Corporate Sponsor Coty Inc. to Raise Awareness for the Cause NEW YORK, May 1, 2013 /PRNewswire/ -- Today, internationally renowned supermodel Georgia May Jagger will join Delete Blood Cancer, part of the world's largest bone marrow donor center, and leading global beauty company Coty Inc. to light up the Empire State Building in red and white to help raise awareness for the fight against blood cancer. Jagger will...

Kcentra(TM) Is the First FDA-Approved 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in the U.S. KING OF PRUSSIA, Pa., April 30, 2013 /PRNewswire/ -- CSL Behring announced today that the U.S. Food and Drug Administration (FDA) approved Kcentra(TM) (Prothrombin Complex Concentrate [Human]), the first non-activated 4-factor prothrombin complex concentrate (PCC) for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (e.g.,...

Scientific collaborators from Yale School of Medicine and University College London (UCL) have uncovered the molecular pathway by which new arteries may form after heart attacks, strokes and other acute illnesses bypassing arteries that are blocked. Their study appears in the April 29 issue of Developmental Cell. Arteries form in utero and during development, but can also form in adults when organs become deprived of oxygen — for example, after a heart attack. The organs release a...